- Home
- NEUP vs SEED Comparison
NEUP vs SEED Comparison
Compare NEUP & SEED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEUP
- SEED
- Stock Information
- Founded
- NEUP 1996
- SEED 1997
- Country
- NEUP United States
- SEED China
- Employees
- NEUP N/A
- SEED N/A
- Industry
- NEUP
- SEED Farming/Seeds/Milling
- Sector
- NEUP
- SEED Consumer Staples
- Exchange
- NEUP Nasdaq
- SEED Nasdaq
- Market Cap
- NEUP 9.3M
- SEED 10.7M
- IPO Year
- NEUP N/A
- SEED N/A
- Fundamental
- Price
- NEUP $4.74
- SEED $1.13
- Analyst Decision
- NEUP Strong Buy
- SEED
- Analyst Count
- NEUP 1
- SEED 0
- Target Price
- NEUP $21.00
- SEED N/A
- AVG Volume (30 Days)
- NEUP 10.9K
- SEED 24.3K
- Earning Date
- NEUP 05-23-2025
- SEED 05-27-2025
- Dividend Yield
- NEUP N/A
- SEED N/A
- EPS Growth
- NEUP N/A
- SEED N/A
- EPS
- NEUP N/A
- SEED 0.46
- Revenue
- NEUP $662,715.00
- SEED $16,163,803.00
- Revenue This Year
- NEUP N/A
- SEED N/A
- Revenue Next Year
- NEUP N/A
- SEED N/A
- P/E Ratio
- NEUP N/A
- SEED $2.66
- Revenue Growth
- NEUP N/A
- SEED 21.51
- 52 Week Low
- NEUP $2.12
- SEED $1.10
- 52 Week High
- NEUP $15.24
- SEED $6.38
- Technical
- Relative Strength Index (RSI)
- NEUP N/A
- SEED 34.83
- Support Level
- NEUP N/A
- SEED $1.10
- Resistance Level
- NEUP N/A
- SEED $1.50
- Average True Range (ATR)
- NEUP 0.00
- SEED 0.08
- MACD
- NEUP 0.00
- SEED 0.01
- Stochastic Oscillator
- NEUP 0.00
- SEED 8.57
About NEUP Neuphoria Therapeutics Inc. Common Stock
Neuphoria Therapeutics Inc is a clinical stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company is advancing its drug candidate, BNC 210, an oral, proprietary, selective negative allosteric modulator of the Alpha7 nicotinic acetylcholine receptor, for the acute treatment of social anxiety disorder and for chronic treatment of post-traumatic stress disorder.
About SEED Origin Agritech Limited
Origin Agritech Ltd is a Chinese agricultural technology company operating in the PRC including seed research and development activities featured in crop seed breeding and genetic improvement. The company's phytase corn was the first transgenic corn to receive the Bio-Safety Certificate from China's Ministry of Agriculture. Origin has established a robust biotechnology seed pipeline including products with glyphosate tolerance and pest resistance (Bt) traits.